Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22777 | 369 | 44.4 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
76 | 3 | NEUROSCIENCES//DOPAMINE//SEROTONIN | 81359 |
75 | 2 | NUCLEUS ACCUMBENS//DOPAMINE//COCAINE | 27976 |
22777 | 1 | BACLOFEN//CGP44532//OPERANT ORAL ALCOHOL SELF ADMINISTRATION | 369 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BACLOFEN | authKW | 970453 | 34% | 9% | 127 |
2 | CGP44532 | authKW | 297898 | 2% | 60% | 6 |
3 | OPERANT ORAL ALCOHOL SELF ADMINISTRATION | authKW | 264801 | 1% | 80% | 4 |
4 | POSTSYNAPTIC DOPAMINE RECEPTOR SUPERSENSITIVITY | authKW | 264801 | 1% | 80% | 4 |
5 | GABAB RECEPTOR | authKW | 214461 | 13% | 6% | 47 |
6 | GAMMA VINYL GABA VIGABATRIN | authKW | 186188 | 1% | 75% | 3 |
7 | POSITIVE ALLOSTERIC MODULATOR OF THE GABAB RECEPTOR GS39783 | authKW | 186188 | 1% | 75% | 3 |
8 | ALCOHOL REINFORCING PROPERTIES | authKW | 165502 | 1% | 100% | 2 |
9 | HIGH DOSE BACLOFEN | authKW | 165502 | 1% | 100% | 2 |
10 | IN VIVO BRAIN DIALYSIS | authKW | 165502 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Substance Abuse | 6733 | 20% | 0% | 74 |
2 | Pharmacology & Pharmacy | 2424 | 47% | 0% | 175 |
3 | Neurosciences | 2211 | 45% | 0% | 167 |
4 | Psychiatry | 1854 | 26% | 0% | 96 |
5 | Behavioral Sciences | 719 | 10% | 0% | 38 |
6 | Toxicology | 37 | 4% | 0% | 14 |
7 | Clinical Neurology | 28 | 5% | 0% | 20 |
8 | Psychology, Clinical | 15 | 2% | 0% | 7 |
9 | Psychology, Biological | 13 | 1% | 0% | 3 |
10 | Medicine, General & Internal | 5 | 4% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CAMTEA | 82751 | 0% | 100% | 1 |
2 | CEDRE BLEU | 82751 | 0% | 100% | 1 |
3 | CERTA LALBATROSU 669 | 82751 | 0% | 100% | 1 |
4 | CH DUNKERQUE | 82751 | 0% | 100% | 1 |
5 | CHIYODA KU DENT | 82751 | 0% | 100% | 1 |
6 | CHRU LE PAN | 82751 | 0% | 100% | 1 |
7 | COMITE COORDINAT TOXICOVIGILANCE | 82751 | 0% | 100% | 1 |
8 | CS A JEU PAUME | 82751 | 0% | 100% | 1 |
9 | DISPOSITIF CAMTEA | 82751 | 0% | 100% | 1 |
10 | EA SPHERE METHODS PATIENT OUTCOMES HLTH | 82751 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SYNAPSE | 9092 | 5% | 1% | 19 |
2 | ALCOHOL AND ALCOHOLISM | 6455 | 4% | 1% | 15 |
3 | PSYCHOPHARMACOLOGY | 5746 | 8% | 0% | 29 |
4 | DRUG AND ALCOHOL DEPENDENCE | 5487 | 5% | 0% | 20 |
5 | ALCOHOL | 2569 | 2% | 0% | 9 |
6 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 2387 | 5% | 0% | 19 |
7 | ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2324 | 4% | 0% | 15 |
8 | BEHAVIOURAL PHARMACOLOGY | 2079 | 2% | 0% | 7 |
9 | ADDICTION BIOLOGY | 1731 | 1% | 0% | 5 |
10 | NEUROPSYCHOPHARMACOLOGY | 1309 | 2% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AGABIO, R , PRETI, A , GESSA, GL , (2013) EFFICACY AND TOLERABILITY OF BACLOFEN IN SUBSTANCE USE DISORDERS: A SYSTEMATIC REVIEW.EUROPEAN ADDICTION RESEARCH. VOL. 19. ISSUE 6. P. 325 -345 | 75 | 51% | 11 |
2 | LORRAI, I , MACCIONI, P , GESSA, GL , COLOMBO, G , (2016) R(+)-BACLOFEN, BUT NOT S(-)-BACLOFEN, ALTERS ALCOHOL SELF-ADMINISTRATION IN ALCOHOL-PREFERRING RATS.FRONTIERS IN PSYCHIATRY. VOL. 7. ISSUE . P. - | 35 | 81% | 0 |
3 | AGABIO, R , COLOMBO, G , (2014) GABA(B) RECEPTOR LIGANDS FOR THE TREATMENT OF ALCOHOL USE DISORDER: PRECLINICAL AND CLINICAL EVIDENCE.FRONTIERS IN NEUROSCIENCE. VOL. 8. ISSUE . P. - | 48 | 51% | 12 |
4 | HALBOUT, B , QUARTA, D , VALERIO, E , HEIDBREDER, CA , HUTCHESON, DM , (2011) THE GABA-B POSITIVE MODULATOR GS39783 DECREASES PSYCHOSTIMULANT CONDITIONED-REINFORCEMENT AND CONDITIONED-REWARD.ADDICTION BIOLOGY. VOL. 16. ISSUE 3. P. 416-427 | 36 | 77% | 13 |
5 | MACCIONI, P , ZARU, A , LOI, B , LOBINA, C , CARAI, MAM , GESSA, GL , CAPRA, A , MUGNAINI, C , PASQUINI, S , CORELLI, F , ET AL (2012) COMPARISON OF THE EFFECT OF THE GABAB RECEPTOR AGONIST, BACLOFEN, AND THE POSITIVE ALLOSTERIC MODULATOR OF THE GABAB RECEPTOR, GS39783, ON ALCOHOL SELF-ADMINISTRATION IN 3 DIFFERENT LINES OF ALCOHOL-PREFERRING RATS.ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. VOL. 36. ISSUE 10. P. 1748-1766 | 47 | 55% | 11 |
6 | FATTORE, L , SPANO, MS , COSSU, G , SCHERMA, M , FRATTA, W , FADDA, P , (2009) BACLOFEN PREVENTS DRUG-INDUCED REINSTATEMENT OF EXTINGUISHED NICOTINE-SEEKING BEHAVIOUR AND NICOTINE PLACE PREFERENCE IN RODENTS.EUROPEAN NEUROPSYCHOPHARMACOLOGY. VOL. 19. ISSUE 7. P. 487-498 | 48 | 52% | 30 |
7 | MACCIONI, P , FANTINI, N , FROESTL, W , CARAI, MAM , GESSA, GL , COLOMBO, G , (2008) SPECIFIC REDUCTION OF ALCOHOL'S MOTIVATIONAL PROPERTIES BY THE POSITIVE ALLOSTERIC MODULATOR OF THE GABA(B) RECEPTOR, GS39783 - COMPARISON WITH THE EFFECT OF THE GABA(B) RECEPTOR DIRECT AGONIST, BACLOFEN.ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. VOL. 32. ISSUE 9. P. 1558 -1564 | 33 | 73% | 23 |
8 | FILIP, M , FRANKOWSKA, M , (2008) GABA(B) RECEPTORS IN DRUG ADDICTION.PHARMACOLOGICAL REPORTS. VOL. 60. ISSUE 6. P. 755 -770 | 61 | 39% | 29 |
9 | PHILLIPS, TJ , REED, C , (2014) TARGETING GABA(B) RECEPTORS FOR ANTI-ABUSE DRUG DISCOVERY.EXPERT OPINION ON DRUG DISCOVERY. VOL. 9. ISSUE 11. P. 1307 -1317 | 43 | 47% | 7 |
10 | ROLLAND, B , AUFFRET, M , FRANCHITTO, N , (2016) SAFETY REPORTS ON THE OFF-LABEL USE OF BACLOFEN FOR ALCOHOL-DEPENDENCE: RECOMMENDATIONS TO IMPROVE CAUSALITY ASSESSMENT.EXPERT OPINION ON DRUG SAFETY. VOL. 15. ISSUE 6. P. 747 -751 | 24 | 75% | 1 |
Classes with closest relation at Level 1 |